Prevalence of the carbapenemase gene (cfiA) among clinical and normal flora isolates of Bacteroides species in Hungary

J Med Microbiol. 2000 May;49(5):427-430. doi: 10.1099/0022-1317-49-5-427.

Abstract

The carbapenemase gene (cfiA) was detected in 4 (5.7%) of 70 clinical isolates of Bacteroides fragilis from different parts of Hungary. Among 24 other Bacteroides species isolated from infectious processes or from normal faecal flora, none was cfiA-positive. The MIC of imipenem and meropenem for all cfiA-positive B. fragilis isolates was < or =0.25 mg/L, but 17% of the B. fragilis and 46% of the non-fragilis Bacteroides isolates exhibited reduced susceptibility to imipenem (MICs 0.5-2 mg/L). Only one of these isolates produced increased levels of beta-lactamase. No difference was observed in the outer-membrane proteins of B. fragilis isolates that harboured the cfiA gene and those with reduced susceptibility to imipenem.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacterial Proteins*
  • Bacteroides / drug effects
  • Bacteroides / enzymology
  • Bacteroides / genetics*
  • Bacteroides Infections / epidemiology
  • Bacteroides Infections / microbiology
  • Blotting, Southern
  • Humans
  • Hungary / epidemiology
  • Imipenem / pharmacology
  • Meropenem
  • Metalloproteins / genetics
  • Microbial Sensitivity Tests
  • Polymerase Chain Reaction
  • Prevalence
  • Thienamycins / pharmacology
  • beta-Lactamases / genetics*

Substances

  • Bacterial Proteins
  • Metalloproteins
  • Thienamycins
  • Imipenem
  • beta-Lactamases
  • carbapenemase
  • Meropenem